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Abstract: Introduction: In the different branches of dentistry, the use of laser to solve different clinical
situations is increasing due to numerous advantages that have been studied in literature since the
70s. Leucoplakia and hyperkeratosis can benefit from laser-assisted treatment. In most cases biopsy
sampling, histological examination and, if no malignant cells are present, the follow-up is needed.
However, even if the lesion is free of dysplasia patients often ask to eliminate these white spots that
are always a cause of concern. Aim: From these numerous requests comes the idea of setting up a
laser-assisted protocol as less invasive as possible to be offered to patients. The aim of the study is
to find a laser-assisted protocol for the surgical excision of leucoplakia and hyperkeratosis that can
both improve the clinical aspect of the lesion and be sustainable for patients. The null hypothesis
has been identified in the following statement: the treatment is effective and efficient at the same
time; where effectiveness was tested with the following criteria: size of the lesion, tactile perception,
discomfort, pain; and efficiency with the following criteria: pain and discomfort perceived during
the treatment. Materials and methods: To collect all data, a specially designed medical record was
used. The diode laser was used with a pulsed mode and the maximum power corresponds to 1.8 W.
No anaesthesia was used. Before laser-assisted treatment, the fibre was activated and was used
with a contact overflowing. Results: Our results show a decrease in the size of the lesion statistically
significant. No pain was referred during treatment, except for a slight burning sensation. Conclusion:
In conclusion we can state that the treatment is both efficient and effective.
Keywords: oral surgery; oral medicine; leucoplakia; hyperkeratosis; laser
1. Introduction
According to the World Health Organization, leucoplakia is defined as a “white patch that cannot
be associated either clinically or histopathologically to other diseases” so the diagnosis is by exclusion.
Leucoplakia is the most common oral precancerous alteration and appears as a white, chronic
lesion, that cannot be removed with rubbing. Leucoplakia is characterized by an abnormal
keratinization of the mucosa. The prevalence in the general population ranges from 0.6% to 5%
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and is more frequent in those between 40 and 50 years old [1]. The cause is multifactorial and there
are several predisposing factors such as: mechanical irritation, dental materials causing galvanic
currents, contact with carcinogens such as tobacco and alcohol and gastroesophageal reflux [2,3].
The predisposition to malignant transformation seems associated to a higher CD8+ cells levels in
premalignant lesion [4].
The presumed diagnosis is based on the anamnesis and the clinical aspect, while the diagnosis
can only be confirmed after both an incisional and excisional biopsy and its subsequent histological
examination [5].
Some epidemiological studies have identified the occasional possibility of spontaneous regression
of leucoplakias. However, in the vast majority of cases various surgical and non-surgical treatments
are proposed such as elimination of the chronic irritative factors, surgical treatment with a scalpel,
electrocautery, laser or cryosurgery; conservative treatment is to be considered only if the patient
denies consent to surgery or if the areas have a low probability of malignant transformation [6–10].
Hyperkeratoses are benign lesions that usually appear in areas subjected to frictional trauma,
for example in adherent gingiva under the prosthetic flanges, the retromolar trigon and the edge of
the tongue, where the patient often tends to bite. During intraoral examination, hyperkeratosis tends
to have a verruciform or corrugated appearance. Histological examination shows hyperkeratosis,
acanthosis, hypergranulosis and inflammation of the stroma.
Although it is benign, some precancerous lesions such as leucoplakia can mimic the characteristics
of the hyperkeratosis. The clinical appearance of the lesion can help clinicians in the differential
diagnosis between leucoplakia and hyperkeratosis; in fact hyperkeratosis shows less definite margins
than the first. Investigating the habits of the patient could be helpful [11,12]. Follow-ups must be
on-going even if the histology does not manifest dysplasia, since hyperkeratosis could evolve towards
a malignant transformation due to the reoccurrence of the trauma.
It has been many years since laser therapy has been introduced in dentistry and in particular in
periodontal field where it succeeded in eliminating pathogenic bacterial niches in inaccessible areas,
such as deep pockets, root concavities and furcation areas in a less- traumatic way [13]. One of the most
effective laser therapy in decontaminating periodontal pockets and in giving improvement in CAL,
PPD and BOP was the photodynamic therapy based on the use of three components: light, oxygen free
radicals and photosensitizer [14–17].
Another option in the treatment of chronic periodontitis is the use of a desiccant agent as an
adjunct to scaling and root planing (SRP). This protocol resulted in a greater reduction in clinical,
microbial and inflammatory mediators compared to SRP alone [18].
The aim of the study is to find a laser-assisted protocol for the surgical excision of leucoplakia and
hyperkeratosis that can both improve the clinical aspect of the lesion and be sustainable for patients.
The null hypothesis has been identified in the following statement: the treatment is effective and
efficient at the same time; where effectiveness was tested with the following criteria: size of the lesion,
tactile perception, discomfort and pain; and efficiency with the following criteria: pain and discomfort
perceived during the treatment.
2. Materials and Methods
The study group consists of 20 patients affected by leucoplakia and hyperkeratosis selected
between October 2017 and March 2018 at the Dr. Peset University Hospital in Valencia and which have
been subjected to a laser treatment.
The sample was selected following specific inclusion and exclusion criteria.
2.1. Inclusion Criteria
Execution of a biopsy and following histopathological examination in order to have the certainty
to select only leucoplakias and hyperkeratosis,
Possibility of completing the clinical trial.
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2.2. Exclusion Criteria
Histopathological presence of dysplasia,
Systemic diseases such as HIV, HBV and HCV infections, celiac disease or physiological conditions
such as pregnancy,
Having performed treatment for hyperkeratosis and leucoplakia in the 2 months prior to the
clinical trial.
During the first visit clinical data of each patient was collected and the informed consent to the
treatment was signed. The patients were also asked about their habits, in order to identify those, which
could be detrimental. The study was approved by the Clinical Research Ethics Committee (CEIC)
(code 09/093), following the principles of Helsinki for human experimentation.
After collecting this data and having examined the patient both from a systemic and dental point
of view, an examination of the lesions was carried out, thus evaluating:
• The site presenting the lesion,
• The histological examination,
• The size of the lesion, in order to have this data, a periodontal probe was used and the greatest
distance between the sides of the lesion was measured,
• How long the lesion was present.
As previously stated, the biopsy and its subsequent histological examination were fundamental:
the presence of cellular atypia, dysplasia or malignant lesions could be excluded, thus making the
patient suitable for receiving laser treatment.
The biopsy was performed at the most significant point of the lesion, in order to also remove a
part of the healthy tissue, useful for identification in the subsequent histological examination. First
of all a 1.8 mL vial of mepivacaine and adrenaline 1:100,000 (OPTOCAIN, Molteni Dental, Milan,
Italy) at the perilesional level were inoculated. After having disinfected the oral mucosa with 0.2%
chlorhexidine, the part of tissue to be extracted was delimited with a 4 or 5 mm biopsy punch and
subsequently extracted with a scalpel, taking care to remove all the layers of the mucosa. A suture was
carried out with simple detached stitches in 4/0 silk, which was removed 7 days later.
The sample was fixed in 10% formalin (BIO-OPTICA, Milan, Italy) and sent to the pathological
anatomy laboratory of the Dr. Peset University Hospital in Valencia. Here it was included in paraffin
then 5-micron thick sections were made, stained with haematoxylin and eosin and analysed under an
optical microscope. Approximately two weeks later the histological examination report was received.
The treatment consisted of four sessions a week and a follow-up visit one month after the last
treatment session. Surgical technique: the surgical technique provided no anaesthesia and a superficial
and fast touch of the lesion, in this way we could observe the removal of the pathological area from
the underlying mucosa, which was then removed manually with the aid of anatomical tweezers. Once
the white area was removed the underlying mucosa appeared to be clinically normal and healed for
second intention.
The protocol stated that at each session before treatment and in the final follow-up session:
• The lesion was measured with periodontal probe and the results were reported in mm,
• The appearance of the lesion was reported,
• The discomfort was measured with an arbitrary numerical scale from 0 to 5 and the type of
discomfort that the patient perceived was noted,
• The pain caused by the lesion was measured, with an NRS scale (Numerical Rating Scale) [19],
• The tactile perception was evaluated, that is the sensation of roughness that the patient felt passing
the tongue on the area where the lesion was present, with an arbitrary numerical scale from 0 to 5.
During each session some aspects that were presented during the seven days since the previous
session were assessed in particular:
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• Discomfort measured with an arbitrary numerical scale from 0 to 5.
• Pain caused by the lesion, measured with the NRS scale [19].
• Tactile perception, measured with an arbitrary numerical scale from 0 to 5.
To perform the treatment a diode laser was used which had a wavelength of 940 nm, the fibre had
a length of 9 mm and diameter of 300 microns; a pulsed mode was selected with a Ton corresponding
to Toff and corresponding to 10−3 s, the period corresponds to the summary of Ton and Toff that
is 2 × 10−3 s. It is also known that the frequency and the period of every electromagnetic wave




2 · 10−3 =
103
2
= 5000 Hz. (1)
When using the pulsed mode, there is both a peak power and average power where the latter
is defined as the percentage of Ton in the period. In this case it stands at 50%. Having set the peak
power at 1.8 W, the average constant power during the emission corresponds to 0.9 W; this allows
intervention without using anaesthetic devices, unless specifically requested by the patient.
Before laser-assisted treatment the fibre was activated, using the special supplied activator. Both
the operator and the patient wore protective glasses. The laser was used with a contact on the mucosa
for about 1 min, the tissue was then left to cool for 30 s and the whole sequence was repeated in order
to perform a total of four sessions in one visit. After each visit the patient was instructed to avoid too
hot and too spicy foods for a few days.
2.3. Statistical Analysis
The data collected during the study were inserted into a database in Excel and the statistical
analysis was performed with one of its applications (Stat). The data were standardized. A test unit
was used in order to find the best criteria that could best evaluate the laser- treatment. For the analyses
there was an intra-examiner agreement. In the first part we analysed the characteristics of the sample,
while in the second phase we focused on the data during the treatment in order to obtain information
regarding both the efficiency and the sustainability of the treatment.
3. Results
3.1. Sample Characteristics
20 patients were included in this study, of which 9 were affected by hyperkeratosis and 11 were
affected by leucoplakia.
The sample consisted of 11 men (55%) with an average age of 55 years old and 9 women (45%)
with an average age of 67 years old, the average age of the sample was of 61 years old. The site of
onset of lesions in the oral cavity of the different patients was homogenous (Figure 1); the year of onset
can be seen in Figure 2.
60% of patients had metals of dental origin such as gold; titanium or mercury derived from
amalgam, 65% were carriers of both crowns and mobile prostheses and 45% of individuals had resin
restorations on various elements. 35% of patients used alcoholic mouthwash, 25% had malocclusions
in particular mono and bilateral cross-bite or third class and that 35% show detrimental habits,
in particular episodes of morsicatio.
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Figure 2. Year of onset of the lesions.
3.2. Analysis of the Lesion Size
The variation of this parameter is evaluated consecutively with one-week intervals between one
observation and the next. As the dimension at time T0 was considered as an independent variable and as
the variable dependent was dimension at time T1, the coefficient of the regression of this analysis was 0.81.
This mea t that the lesion ime sion between the two time intervals taken into consideration, reduced
by an verage of 19%. This ame reasoning was applied o the independent and dependent variables
respectively before T1 and T2, then T2 and T3 and finally T3 and T4 The coefficients of th regression
analysis obtained are, in order, 0.39; 0.60; 0.80. The size between the different time intervals is reduced on
average by 61%, 40% and 20% respectively. The P value was always inferior to 0.05% (Table 1).
Table 1. Regression analysis, the parameter that has been used was: coefficient, significance and
coefficient of determination.
Regression: Lesion Dimension T1
Constant Lesion Dimension T0
Coefficient −8.5327 0.814990
Std error of coef 11.7132 0.03492
t-ratio −0.7285 23.3347
Significance 4756.97% 0.0000 %
Beta-weight 0.9839
Standard error of regression 42.4721
Coefficient of determination 96.80%
Adjusted coef of determination 96.62%
Number of observation 20
Residual degrees of freedom 18
t-statistic for computing
95% confidence intervals 2.1009
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3.3. Discomfort Analysis
The perception of the discomfort caused by the lesion before the laser therapy results, on average,
in the scale selected for the measurement of this parameter, approximate to zero. The discomfort
perceived during the treatment stands at average values (between 2.5 and 2.0) and tends to decrease
less evidently in the short term, while in the medium to long term it follows a decreasing trend from
values of 2.6 at T0 to 1.9 at T4. The values show that on average the variable assumes significant values
for all observations and that the trend decreased particularly between the second and third week of
treatment. The discomfort was always described as a burning sensation (Figure 3).
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Figure 3. Trend of discomfort perceived throug t t e tre t ent. The data were divided as f llow:
discomfort felt before the patient was subjected to treatment, during irradiation of the lesion and in the
days following the session. The data refer to the entire month of observation.
3.4. Tactile Perception
It remains ubstantially unchanged bet uring the treatment bu the overall
tendency of the values i to decrease almost constantly over time, starting at an average of 3. t to
0.5 at T4 (Figure 4).
3.5. Pain: Not Perceived
As previously stated in this study both patients with simple hyperkeratotic lesions and patients
with leucoplakia were included. In order to highlight if the treatment has a different efficacy between
the two lesions, the patients were divided into two groups taking into consideration the nature of the
lesions. For each group we analysed the same parameters used in the previous paragraphs and then
we compared the results. Regarding discomfort, tactile perception and pain there are not substantial
differences neither between the two groups nor between the groups and the general trend previously
described. The only difference is in the variation of the size: leucoplakia follows the general trend,
in fact the size reduced by 17% between T0 and T1, between T1 and T2 the size reduced by 63%,
between T2 and T3 a variation of 39% occurred and finally between T3 and T4 there was a variation of
36%; in all cases the results were statistically significant. With regard to patients with hyperkeratosis,
the dimensional variation shows a constant reduction during all the observations, the data showed:
between T0 and T1 there was a reduction of 20%, between T1 and T2 the dimension varied by 28% and
continued to do so in the following weeks of observation.
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4. Discussion
Laser-assisted treatment has some advantages compared to traditional surgical techniques.
The main advantage common to all types of laser treatment is photocoagulation of lymphatic,
hematic and nerve endings thus giving less intraoperative bleeding, less oedema and post-intervention
pain. The placement of sutures is rarely necessary.
The diode laser is not indicated as the main laser for soft tissue surgery but its versatility of use
led us to choose it for the study.
The diode laser is a semiconductor laser and exists in different wavelengths: from 980 nm that
has greater cutting capacity and fibres that do not need to be activated, up to 810 nm which has a more
biostimulatory capacity. This laser therefore has dual functionality [14,17,20]. The protocol used in this
study aimed to exploit both the cutting capacity and the biostimulatory capacity; in particular, the latter
was always used after the surgical phase. This helped to further reduce postoperative discomfort,
oedema and to have a better, faster healing without retractable cicatrized outcomes or functional
outcomes. Studies report that the laser beam activity on myofibroblasts result in reduced proliferation
which results in minor dysfunctional outcomes and furthermore impacts on vessel proliferation,
the synthesis of collagen and the anti-inflammatory capacity. These effects are closely related to the
laser settings (fibre, power, exposure time). The best results, in terms of healing, occur with a fluency
of about 4 J/cm2 [21–24].
Some studies refer to the use of lasers to treat leukoplasic and hyperkeratotic lesions but the
various studies do not report the same para eters with regard to power settings, exposure time and
application distance and fibre iameter [9,10,25–27].
Cons quently, in our study it was difficult to compare our parameters with previously reported
in the lit rature, because of a non-homogeneous umb r of terms of comparison.
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Other studies reported the evaluation of the recurrence rate and the rate of malignant
transformation [1,7,23,28], however no mention about the efficacy of the treatment in the short term,
sustainability or invasiveness was reported.
Our protocol involves the use of the diode laser in pulsed mode with a Ton and a Toff of 110−3 s
and a frequency of 5000 Hz. These settings were chosen in order to allow, during the emission phase of
the ray, a thermal relaxation time corresponding to the Toff, which resulted in diminished overheating
of tissues.
The pulsed mode was chosen in order to avoid the harmful overheating of the tissue already
mentioned above; this mode allowed us to alternate a lower average power, that corresponded to the
percentage of Ton in the period, with a high power peak equal to the maximum power set. In our
protocol the percentage of Ton in the period is 50%, thus setting an average power of 0.9 W and a peak
power of 1.8 W. With these settings anaesthesia was not required to perform the treatment unlike all
the other protocols found in literature.
In order to prevent the treatment from becoming unsustainable for the individual, it was decided
to irradiate the tissue for a relatively short time (about 1 min) and then leave 30 s of relaxation. This
was a variation of what was found in the literature where the irradiation time was on average over
8 min [8,9,23,29].
To evaluate the effectiveness of laser-assisted treatment, the following parameters and their
behaviour were taken into account during the observation period:




The treatment was defined effective if there was a decreasing trend of all the parameters listed
above, partially effective if only some parameters reduced or not effective if, compared to the beginning
of the observation, the parameters have remained unchanged.
In order to evaluate the efficiency of the treatment and its sustainability for the patient, the pain
and discomfort perceived during the irradiation of the lesion were considered. Treatment is considered
sustainable for the patient if these parameters show medium-low values and have a decreasing trend
during the four weeks of observation, if this does not happen the treatment is considered unsustainable
for the patient.
4.1. Effectiveness
Analysis of the data shows that treatment can be defined as effective in 15 patients (75%), partially
effective in 5 subjects (25%) and not effective in any of the individuals.
In five patients, belonging to the group where the treatment can be defined as effective, the lesion
had completely disappeared in four weeks; while in two individuals the lesion had regressed already
during the third week.
In those where the treatment is partially effective, the size of the lesion and the discomfort
remained constant. In these cases the lesion did not decrease in size in a clear way but the whitish
pigmentation appeared less intense.
4.2. Efficiency
The treatment can therefore be considered efficient for the following reasons: first, the values
reported by the subjects are average values and their trend is, even if slightly, decreasing; all patients
completed the clinical trial and reported less post-intervention discomfort respect to the initial biopsy
performed with a blade.
Because no anaesthesia was administered and so neither adrenalin, there were the possibility of
having an intraoperative bleeding that could compromise the visibility of the operative field. Thanks
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to the use of the laser we could provide a bloodless operating field with an excellent visibility of the
lesion margins and a smoother treatment, defined the low invasiveness of laser-assisted treatment.
Since the margins were well photocoagulated, no stitches were placed but the area was left to
heal by second intention.
After seven days, the complete epithelialization of the area was observed in almost all cases,
only in two cases there was still presence of fibrin deposits. None of the patients had an infection of
bacterial origin of the wound.
At the end of the treatment there were no retrospective cicatricle outcomes. Regard to lesions
that were placed in areas of functional interest, such as the labial commissure, they did not report any
functional existences of any kind.
In the following figures the data from lesions treated with our protocol at time T0 and four weeks
later, at time T4 (Figures 5a,b, 6a,b and 7a,b)
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Figure 7. (a) Whitish and irregular area in the gingival mucosa. (b) Three weeks after the beginning 
of the treatment. 
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5. Conclusions
On the basis of our results, laser-assisted treatment can be considered successful. In the future
it will be possible to recruit more patients in order to correlate systemic factors, such as diabetes,
anaemia or gastroesophageal reflux, with the effects of the treatment in order to evaluate if those
factors influence the result of the therapy. Another aspect to consider could be the rate of recurrence
and malignant transformation in a longer follow-up; in this study we follow the patients for only one
month after the end of the treatment and no significant differences were found since the last irradiation.
In conclusion we can state that the treatment is a valid alternative to conventional surgery with
a scalpel if the lesion is bigger than 8 mm, below this limit it is better to completely eliminate the
lesion during a biopsy. Lesions with a maximum size of 2 cm can regress during the four sessions set,
obviously the larger the lesion, the more time needed to allow the lesion to regress.
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